These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

103 related articles for article (PubMed ID: 33870257)

  • 41. Conflicting COVID-19 excess mortality estimates - Authors' reply.
    Hay SI; Murray CJL;
    Lancet; 2023 Feb; 401(10375):433-434. PubMed ID: 36774152
    [No Abstract]   [Full Text] [Related]  

  • 42. Estimating vulnerability to COVID-19 in India - Authors' reply.
    Acharya R; Porwal A
    Lancet Glob Health; 2020 Dec; 8(12):e1467. PubMed ID: 33220209
    [No Abstract]   [Full Text] [Related]  

  • 43. Using EM data to understand COVID-19 pathophysiology - Authors' reply.
    Dittmayer C; Meinhardt J; Radbruch H; Radke J; Heppner BI; Heppner FL; Stenzel W; Holland G; Laue M
    Lancet; 2021 Jan; 397(10270):197-198. PubMed ID: 33453781
    [No Abstract]   [Full Text] [Related]  

  • 44. COVID-19 and myocardial infarction - Authors' reply.
    Katsoularis I; Fonseca-Rodríguez O; Farrington P; Lindmark K; Connolly AF
    Lancet; 2021 Nov; 398(10315):1964. PubMed ID: 34838176
    [No Abstract]   [Full Text] [Related]  

  • 45. Authors' Reply to Sprengholz and Betsch: "Willingness to Pay for a COVID-19 Vaccine".
    García LY; Cerda AA
    Appl Health Econ Health Policy; 2021 Jul; 19(4):623-624. PubMed ID: 33973149
    [No Abstract]   [Full Text] [Related]  

  • 46. Prevention of COVID-19 in patients with IBD - Authors' reply.
    Ding NS; An P; Dong W; Ding Y
    Lancet Gastroenterol Hepatol; 2020 Jul; 5(7):640-641. PubMed ID: 32553142
    [No Abstract]   [Full Text] [Related]  

  • 47. COVID-19 in Children With Tuberculosis: Methodological Issues: Authors' Reply.
    Mane S; Pustake M
    Indian Pediatr; 2022 Dec; 59(12):960. PubMed ID: 36511217
    [No Abstract]   [Full Text] [Related]  

  • 48. Does COVID-19 Not Have Any Impact on Children With Tuberculosis?: Authors' Reply.
    Mane S; Pustake M
    Indian Pediatr; 2022 Nov; 59(11):891. PubMed ID: 36370023
    [No Abstract]   [Full Text] [Related]  

  • 49. Authors' Reply to: Minimizing Selection and Classification Biases Comment on "Clinical Characteristics and Prognostic Factors for Intensive Care Unit Admission of Patients With COVID-19: Retrospective Study Using Machine Learning and Natural Language Processing".
    Izquierdo JL; Soriano JB
    J Med Internet Res; 2021 May; 23(5):e29405. PubMed ID: 33989164
    [No Abstract]   [Full Text] [Related]  

  • 50. Time course of exercise capacity in patients recovering from COVID-19-associated pneumonia. Authors' reply.
    Zampogna E; Ambrosino N; Migliori GB; Visca D
    J Bras Pneumol; 2021 Sep; 47(4):e20210328. PubMed ID: 34495184
    [No Abstract]   [Full Text] [Related]  

  • 51. Management of diabetes in patients with COVID-19 - Authors' reply.
    Bornstein SR; Zimmet P; Rubino F; Ludwig B
    Lancet Diabetes Endocrinol; 2020 Aug; 8(8):669-670. PubMed ID: 32707113
    [No Abstract]   [Full Text] [Related]  

  • 52. Authors' Reply to: "Affection of Cranial Nerves in COVID-19 Patients Should Prompt Suspicion of Guillain-Barré Syndrome".
    Decavel P; Nahmias O; Petit C; Tatu L
    Eur Neurol; 2022; 85(3):210-211. PubMed ID: 35104817
    [No Abstract]   [Full Text] [Related]  

  • 53. A glimpse into long COVID and symptoms - Authors' reply.
    Huang L; Gu X; Zhang H; Cao B
    Lancet Respir Med; 2022 Sep; 10(9):e82. PubMed ID: 35697052
    [No Abstract]   [Full Text] [Related]  

  • 54. Call for a pan-European COVID-19 response must be comprehensive - Authors' reply.
    Priesemann V; Brinkmann MM; Ciesek S; Cuschieri S; Czypionka T; Giordano G; Hanson C; Hens N; Iftekhar E; Klimek P; Kretzschmar M; Peichl A; Perc M; Sannino F; Schernhammer E; Schmidt A; Staines A; Szczurek E
    Lancet; 2021 Apr; 397(10284):1541. PubMed ID: 33894827
    [No Abstract]   [Full Text] [Related]  

  • 55. Antipsychotics and COVID-19: the debate goes on - Authors' reply.
    De Picker L; Mazza MG; Vai B
    Lancet Psychiatry; 2021 Dec; 8(12):1030-1031. PubMed ID: 34801117
    [No Abstract]   [Full Text] [Related]  

  • 56. COVID-19 vaccine efficacy data: solid enough to delay second dose? - Authors' reply.
    Amit S; Regev-Yochay G; Afek A; Kreiss Y; Leshem E
    Lancet; 2021 Jun; 397(10291):2249-2250. PubMed ID: 34119061
    [No Abstract]   [Full Text] [Related]  

  • 57. Frailty and mortality in patients with COVID-19 - Authors' reply.
    McCarthy K; Hewitt J; Myint PK; Quinn T; Carter B
    Lancet Public Health; 2020 Nov; 5(11):e582. PubMed ID: 33120043
    [No Abstract]   [Full Text] [Related]  

  • 58. Pulmonary Rehabilitation in Patients Recovering from COVID-19: Authors' Reply.
    Zampogna E; Paneroni M; Vitacca M; Ambrosino N
    Respiration; 2021; 100(9):935-936. PubMed ID: 34315159
    [No Abstract]   [Full Text] [Related]  

  • 59. Critically ill COVID-19 patients in Africa: it is time for quality registry data - Authors' reply.
    Biccard BM; Thomson D; Miller M; Taylor EH; Gopalan PD
    Lancet; 2021 Aug; 398(10299):486-487. PubMed ID: 34364516
    [No Abstract]   [Full Text] [Related]  

  • 60. Authors' reply to: "Neuropathologic findings in COVID-19 patients should be correlated with clinical neurologic abnormalities".
    Eschbacher KL; Larsen RA; Reichard RR
    J Neuropathol Exp Neurol; 2023 Feb; 82(3):278-279. PubMed ID: 36625551
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.